Antisense oligonucleotides | Targets |
---|---|
 | Cancer |
+T*+T*+G*A*T*G*G*G*G*A*A*C*T*+T*+G*+G | ABL1,BLK,FGR,HCK. |
+G*+C*+C*A*A*G*C*C*A*A*A*+G*+T*+C | ACVR2B,ARAF,CHECK1,FGR. |
+A*+G*+G*T*C*C*A*G*T*T*T*+C*+T*+G | ATR,MKI67,PNK3. |
+T*+G*+T*C*A*G*C*T*G*T*C*+A*+T*+T | BCL2,HIF2,PSMA6. |
+T*+T*+G*G*T*T*T*C*C*T*T*+T*+G*+C | BIRC5,HK2,USP34. |
+G*+G*+C*C*A*G*G*C*C*A*A*A*+G*+T*+C | CAMK2A,CDK4,CDK16,FIP1L1, |
 | HCK,IRAK1,PDGFRA. |
+A*+C*+C*A*G*C*T*G*C*T*T*G*+A*+A*+G | CCNE2,FGR1,FGR3,FGR4. |
+G*+G*+C*C*A*G*G*C*C*A*A*A*G*+T*+C*+A | CDK4,CDK16,FIP1L1,HCK,MAPK(1&9). |
+G*+C*+C*A*T*C*C*A*C*T*T*+C*+A*+C | C-KIT,C-MET,CSF1R,FGFR1,FGFR3, |
 | FGFR4,FIP1L1,MST1R,PDGFRA. |
+T*+T*+G*C*G*G*G*C*A*G*C*C*+A*+G*+G | CSK,EPHB2,FGR3,FGR4,TNK2,RIPK4. |
+G*+T*+T*A*C*A*A*G*C*A*T*+C*+A*+T | DOCK7,TGFB2,USP14. |
+A*+G*+C*C*A*C*T*G*G*A*T*+G*+T*+G | E2F1,FGR1,FGR3,FGR4,HSPA12A. |
+T*+G*+T*G*A*T*A*C*T*T*T*+C*+T*+G | EBAG9,MCL1,PTGS2,TMED7-TICAM2. |
+A*+C*+A*T*C*A*C*T*C*T*G*G*T*G*+G*+G*+T | EGFR,FGFR1,HER2. |
+C*+A*+C*C*T*G*G*T*A*G*G*C*+G*+C*+A | FGFR1,FGFR4,TERT. |
+T*+C*+A*C*T*G*T*A*C*A*C*+C*+T*+T | FGR1,FGR3,GRB7. |
+C*+A*+C*C*T*G*G*T*A*G*G*C*+G*+C*+A | FGR1,FGR4,TERT. |
 | Immunological diseases |
+C*+C*+A*A*C*C*T*T*C*A*+C*+A*+C | CARD9,IL7R,RPL5. |
+T*+C*+T*C*C*T*T*C*C*T*C*T*G*+C*+T*+T | KRT17,NLRP1. |
+C*+C*+G*T*G*G*G*T*C*C*C*T*G*+G*+C*+A | ILR6,TLR9. |